Description

Afelimomab is a monoclonal antibody fragment specifically designed for targeted therapeutic intervention. This compound is of significant interest in advanced pharmaceutical research and development due to its precise biological activity. It is primarily utilized by biopharmaceutical companies and research institutions engaged in the development of novel immunotherapies and treatments for inflammatory conditions.

Application

• Primary research and development of novel immunomodulatory therapies.
• Investigational use in preclinical and clinical studies targeting specific inflammatory pathways.
• As a critical reference standard in bioanalytical method development and validation.
• Component in the formulation of specialized diagnostic assay kits.
• Tool compound for studying cell signaling and receptor interactions in immunology.
• Potential use in the development of targeted drug delivery systems.

Basic Information

Product Name	Afelimomab
CAS No.	156227-98-4
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	Anti-TNFα Fab Fragment; F(ab')2 anti-murine TNF; Anti-TNF Monoclonal Antibody Fragment; Afelimomab (INN); Anti-TNF-alpha Fab; Murine Anti-TNF Fab Fragment; TNF-alpha Inhibitor Fab
EINECS	Contact for details

Quality Control

Our Afelimomab is produced and handled under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure identity, purity, potency, and consistency. A comprehensive Certificate of Analysis (COA) detailing specifications such as purity (by HPLC), biological activity, endotoxin levels, and sterility (where applicable) is provided to support your research and regulatory requirements.

Storage

Preserve in a tightly closed container, protected from light. Store at the recommended temperature as specified on the label, typically at 2-8°C for long-term stability. Due to its hygroscopic (moisture-sensitive) nature, the product should be kept under controlled humidity conditions and allowed to equilibrate to room temperature before opening to prevent condensation.

Specification

Item	Specification
Appearance	White to off-white solid or lyophilized powder
Identification (HPLC/MS)	Conforms to reference standard
Purity (HPLC)	≥ 95.0%
Protein Content	As per COA
Biological Activity	As per COA
Endotoxin	< 1.0 EU/mg
Solubility	Soluble in appropriate aqueous buffers

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.